ARCH Venture Partners

ARCH Venture Partners (ARCH) is an American venture capital firm based in Chicago. The firm mainly invests in companies from the biotechnology industry but has also invested other industries such as semiconductors and technology.

ARCH Venture Management LLC
ARCH Venture Partners
TypePrivate
IndustryVenture Capital
Founded1986 (1986)
Founders
  • Steven Lazarus
  • Clinton Bybee
  • Keith Crandell
  • Robert Nelsen
HeadquartersChicago, Illinois, U.S.
ProductsInvestments
AUMUS$9 billion (2022)
Websitearchventure.com
Footnotes / references
[1][2]

Background

In 1986, the ARCH Development Corporation was initially created by the University of Chicago and the Argonne National Laboratory as a non-profit initiative to commercialize the technology developed by them.[3][4][5][6][7][8] The name ARCH reflects this origin with "AR" from Argonne and "CH" from the University of Chicago.[7] ARCH Development Corporation was led by Steven Lazarus who was Deputy Dean of University of Chicago Booth School of Business.[6][7][9] Lazarus noted that that spin-off company plans were hindered by lack of external capital, so a venture fund would be created to provide it.[7][9][10]

In 1989, the University of Chicago and Argonne National Laboratory provided around $9 million in capital for ARCH Development Corporation's first fund, ARCH Venture Fund Limited Partnership.[3][7][8][9] It was believed to be first venture capital fund to be established between a major U.S. laboratory and university and the first to be fully pledged by a group of investors.[9] The first fund invested in twelve companies with 7-8 of them being successful investments.[6][7]

After the success of the first fund, the university stated it no longer considered ARCH Development Corporation as an experiment and wasn't comfortable continuing as general partner of a venture fund so it proposed that ARCH Development Corporation would focus on licensing and business development of technologies while capital raising will be done outside the university .[6][8] In 1992, Lazarus along with Booth Graduate students, Clint Bybee, Keith Crandell and Bob Nelsen left the university to set up ARCH Venture Partners as an independent firm to raise capital. [6][7][8]

The firm mainly invests in companies that are in the biotechnology, semiconductors and computing fields.[2][3][4][5]

ARCH Venture Partners is headquartered in Chicago with additional offices in Seattle, San Francisco and Dublin.[11]

On June 10, 2018, Lazarus passed away and the firm's management was succeeded by the other co-founders.[12]

Funds
Fund[13] Vintage Year Committed Capital ($m)
ARCH Venture Fund I 1989 USD 9
ARCH Venture Fund II 1993 USD 31
ARCH Venture Fund III 1996 USD 107
ARCH Venture Fund IV 1999 USD 175
ARCH Venture Fund V 2001 USD 380
ARCH Venture Fund VI 2004 USD 350
ARCH Venture Fund VII 2007 USD 400
ARCH Venture Fund VIII 2014 USD 560
ARCH Venture Fund IX 2016 USD 1,100
ARCH Venture Fund X 2020 USD 1,460
ARCH Venture Fund XI[14] 2021 USD 1,941
ARCH Venture Fund XII[3][14] 2022 USD 2,975

References
  1. "Form ADV" (PDF). SEC. Retrieved 24 December 2022.
  2. "American VC firm Arch launches $3bn biomedical fund with eye on Japan - Nikkei Asia". 13 June 2022. Archived from the original on 2022-06-13.
  3. "ARCH Venture Partners: Stay in School - | Venture Capital Journal". 2021-06-21. Archived from the original on 2021-06-21. Retrieved 2022-12-24.
  4. "ARCH raises $350M fund". www.bizjournals.com. Mar 11, 2004. Retrieved 2022-12-24.
  5. "Biotech investor raises $3 billion in new fund". Crain's Chicago Business. 2022-06-29. Retrieved 2022-12-24.
  6. "Done Deals - Venture Capitalists Tell Their Stories - Lazarus". HBS Working Knowledge. Retrieved 2022-12-24.
  7. "Interview with David Cruikshank | UNC Innovation & Entrepreneurship | Innovate Carolina". innovate.unc.edu. 2019-11-15. Retrieved 2022-12-24.
  8. Sciences (US), National Academy of; Roundtable, National Academy of Engineering (US) and Institute of Medicine (US) Government-University-Industry Research (1999). Presentation by Teri Willey Vice-President, ARCH Development Corporation at the Workshop on Overcoming Barriers to Collaborative Research March 23–24, 1998. National Academies Press (US).
  9. "U. OF C., LAB FORM VENTURE CAPITAL FUND". Chicago Tribune. 13 February 1989. Retrieved 2022-12-24.
  10. "University Fund to Turn Inventions Into Products". Arlington Heights Daily Herald. Associated Press. February 15, 1989. p. Section 4, page 2.
  11. "Contact". ARCH Venture Partners. Retrieved 2022-12-24.
  12. "STEVEN LAZARUS Obituary (1931 - 2018) - Chicago, IL - The Washington Post". Legacy.com. Retrieved 2023-01-02.
  13. "ARCH Venture | Palico". www.palico.com. Retrieved 2022-12-24.
  14. "Proskauer Advises ARCH Venture Partners in Closing of $2.975 Billion Fund XII - Insights - Proskauer Rose LLP". Proskauer. Retrieved 2022-12-24.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.